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Background
Patients with peanut allergy are advised to strictly avoid
peanuts in their diet and to carry an emergency kit includ-
ing self-injectable epinephrine at all times.
The aim of the study was to determine to which
extent peanut allergic children in Germany are provided
with self-injectable epinephrine and if they had received
professional dietary advice.
Methods
63 peanut allergic children (median: age 6 years; peanut-
specific IgE 73,5kU/l) who participated in an oral immu-
notherapy (OIT)-study were enrolled. Data concerning age
of diagnosis, provision with self-injectable epinephrine,
professional advice and performance of a peanut-free diet
as well as the characterization of accidental allergic reac-
tions to peanut (grade of severity I-V) were collected at
their baseline visit of the OIT-study.
Results
At baseline visit, 17/63 children (27%) had not been
provided with self-injectable epinephrine although the
diagnosis of their peanut allergy was already made 4 years
(median) ago. Five of these 17 children had at least one
severe allergic reaction after accidental peanut consump-
tion (grade IV) in their history. 27/63 children (43%) had
not received self-injectable epinephrine at initial diagnosis
but later in their life. In 13 of these 27 cases self-injectable
epinephrine was prescribed only after at least one severe
allergic reaction to peanut (grade IV). 19/63 children
(30%) had received self-injectable epinephrine directly at
initial diagnosis. A strict avoidance of peanut was
performed by 51/63 families (82%). 12/63 families (18%)
did not avoid products labelled with “may contain traces
of peanuts”. Only 13/63 families (21%) had received diet-
ary advice from a dietician.
Conclusion
Currently, peanut allergic children are not sufficiently pro-
vided with self-injectable epinephrine and do not receive
enough professional dietary advice in Germany. Accidental
allergic reactions are common. Therefore we recommend
prescribing an emergency kit including self-injectable epi-
nephrine directly at initial diagnosis. Furthermore families
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